Post-marketing studies are vital for continuing to monitor the safety, efficacy and optimal use of marketed drugs and biologics. SCRO has the know-how and resources to help you plan and conduct post-marketing studies to gather real world clinical data in order to assess your product’s safety and efficacy profile throughout its lifecycle.
Phase IV studies, or post-marketing studies, are performed after the product has been approved for market and are important large-scale studies that can identify previously unknown safety issues.
In addition, post-marketing studies can be used to study a specific subpopulation of patients; compare your product to similar drugs or biologics on the market; or monitor long-term-effectiveness, health economy or product quality.
Gain better understanding
Let SCRO support you in planning and carrying out your post-marketing study from start to finish, or by providing standalone services that meet your needs, budget and timelines.